Table 3.
All Patients at the Week 0 | n | r | p |
CDI vs. PON-L | 58 | −0.221 | 0.048 |
CDI vs. PON-A | 58 | −0.087 | 0.257 |
PON-L vs. HDL | 58 | 0.295 | 0.018 |
PON-A vs. HDL | 58 | 0.010 | 0.472 |
Om3 Group at the Week 6 | n | r | p |
CDI vs. PON-L | 28 | −0.075 | 0.353 |
CDI vs. PON-A | 28 | −0.304 | 0.058 |
CDI vs. HDL | 28 | 0.028 | 0.446 |
HDL vs. PON-L | 28 | 0.057 | 0.388 |
HDL vs. PON-A | 28 | −0.013 | 0.474 |
Om6 Group at the Week 6 | n | r | p |
CDI vs. PON-L | 29 | −0.136 | 0.246 |
CDI vs. PON-A | 28 | −0.184 | 0.175 |
CDI vs. HDL | 28 | −0.068 | 0.369 |
HDL vs. PON-L | 29 | 0.453 | 0.009 |
HDL vs. PON-A | 27 | 0.067 | 0.369 |
CDI—Children’s Depression Inventory, HDL—high density lipoprotein, L-HDL—large HDL, I-HDL—intermediate HDL, PON-L—paraoxonase 1 with lactonase activity, PON-A—paraoxonase activity with arylesterase activity, Om3—omega-3 group, Om6—omega-6 group, n—number of subjects, r—correlation coefficient, p—significance.